Ignite Creation Date:
2024-05-05 @ 11:22 AM
Last Modification Date:
2024-10-26 @ 9:06 AM
Study NCT ID:
NCT00010309
Status:
UNKNOWN
Last Update Posted:
2014-01-06
First Post:
2001-02-02
Brief Title:
Vaccine Therapy in Treating Patients Who Have Stage II Stage III or Stage IV Melanoma
Sponsor:
Genzyme a Sanofi Company
Organization:
National Cancer Institute NCI
Key Dates - Follows AllAPIJSON File Order
Start Date:
2000-11
Start Date Type:
None
Primary Completion Date:
None
Primary Completion Date Type:
None
Completion Date:
None
Completion Date Type:
None
First Submit Date:
2001-02-02
First Submit QC Date:
November 10 2003
Study First Post Date:
2003-11-11
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2014-01-03
Last Update Post Date:
2014-01-06
Last Update Post Date Type:
ESTIMATED